Skip to main content

Research Repository

Advanced Search

Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: The ICIQ-IBD

Bassett, Paul; Dibley, Lesley; Norton, Christine; Cotterill, Nikki; Basssett, P

Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: The ICIQ-IBD Thumbnail


Authors

Paul Bassett

Lesley Dibley

Christine Norton

Profile Image

N Nikki Cotterill Nikki.Cotterill@uwe.ac.uk
Professor of Long Term Conditions (Continence Care)

P Basssett



Abstract

© 2016 Wolters Kluwer Health, Inc. All rights reserved. Background and aims Faecal incontinence (FI) related to inflammatory bowel disease (IBD) affects up to 74% of patients and is often under-reported in clinical encounters. A previous study found that several important bowel function concerns of patients with IBD are not addressed by existing FI questionnaires, especially differences between symptoms in relapse and remission. We have therefore adapted an existing FI assessment questionnaire specifically for patients with IBD. Methods A total of 190 people participated in this study. Phase 1 (development): the initial draft of the new questionnaire was developed from previously collected data and from results of a modified Delphi survey of IBD clinicians; questions were refined through six rounds of cognitive interviewing (n=24). Phase 2 (validation): the final version was tested (n=166) and retested (n =143) 3'4 weeks later. Results Missing data were minimal (1'4%). Weighted kappa analysis showed moderate-to-good agreement for test'retest data. Factor rotational analysis revealed the relationship of questions with each other. The new questionnaire has two domains: 'Symptoms and 'Quality of Life', recording remission and relapse scores with simple summary scores for each. An additional 10 stand-alone questions address issues of specific concern to patients with IBD. The questionnaire demonstrates the ability to capture changing symptoms and concerns between remission and relapse. Conclusion The new questionnaire has good content validity and is stable and reliable. Further testing to establish sensitivity to change is needed. The scale can be used by patients, researchers and practitioners to assess severity, fluctuation and impact of IBD-related FI.

Citation

Bassett, P., Dibley, L., Norton, C., Cotterill, N., & Basssett, P. (2016). Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: The ICIQ-IBD. European Journal of Gastroenterology and Hepatology, 28(2), 233-239. https://doi.org/10.1097/MEG.0000000000000513

Journal Article Type Article
Acceptance Date Oct 6, 2015
Publication Date Jan 1, 2016
Deposit Date Jul 17, 2018
Publicly Available Date Jul 17, 2018
Journal European Journal of Gastroenterology and Hepatology
Print ISSN 0954-691X
Electronic ISSN 1473-5687
Publisher Lippincott, Williams & Wilkins
Peer Reviewed Peer Reviewed
Volume 28
Issue 2
Pages 233-239
DOI https://doi.org/10.1097/MEG.0000000000000513
Keywords continence, assessment, inflammatory bowel disease, questionnaires, patient-reported outcomes
Public URL https://uwe-repository.worktribe.com/output/913883
Publisher URL https://journals.lww.com/eurojgh/Abstract/2016/02000/Development_and_initial_validation_of_a.18.aspx
Additional Information Additional Information : This is the author's accepted manuscript. The final published version is available here: https://journals.lww.com/eurojgh/Abstract/2016/02000/Development_and_initial_validation_of_a.18.aspx.

Files








You might also like



Downloadable Citations